Protein clues could predict amyloidosis onset
NCT ID NCT03431896
First seen Feb 28, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study followed 37 people with a genetic risk for hereditary ATTR amyloidosis over five years. Researchers measured a specific misfolded protein in the blood to see if it could signal when the disease starts or worsens. No treatments were tested; the goal was simply to learn how the disease progresses early on.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMYLOIDOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.